BR0213557A - Método para a sìntese de uma 2-aralquiloxiadenosina ou uma 2-alcoxiadenosina e processo para a preparação de um composto - Google Patents

Método para a sìntese de uma 2-aralquiloxiadenosina ou uma 2-alcoxiadenosina e processo para a preparação de um composto

Info

Publication number
BR0213557A
BR0213557A BR0213557-4A BR0213557A BR0213557A BR 0213557 A BR0213557 A BR 0213557A BR 0213557 A BR0213557 A BR 0213557A BR 0213557 A BR0213557 A BR 0213557A
Authority
BR
Brazil
Prior art keywords
compound
synthesis
aralkyloxyadenosine
alkoxydenosine
preparation
Prior art date
Application number
BR0213557-4A
Other languages
English (en)
Inventor
Allan R Moorman
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of BR0213557A publication Critical patent/BR0213557A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"MéTODO PARA A SìNTESE DE UMA 2-ARALQUILOXIADENOSINA OU UMA 2-ALCOXIADENOSINA E PROCESSO PARA A PREPARAçãO DE UM COMPOSTO". A invenção fornece novos métodos para a síntese de 2-aralquiloxiadenosinas e 2-alcoxiadenosinas. A invenção é particularmente útil para a síntese de 2-[2-(4-clorofenil)etóxi]adenosina. Os métodos preferidos da invenção incluem ativar um composto de guanosina seguido pela hidrólise; alquilar o composto hidrolisado com aminação subsequente para fornecer um composto de 2-aralquiloxiadenosina ou um composto de 2-alcoxiadenosina.
BR0213557-4A 2001-10-25 2002-10-24 Método para a sìntese de uma 2-aralquiloxiadenosina ou uma 2-alcoxiadenosina e processo para a preparação de um composto BR0213557A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33516901P 2001-10-25 2001-10-25
US37572302P 2002-04-26 2002-04-26
PCT/US2002/034313 WO2003035662A1 (en) 2001-10-25 2002-10-24 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines

Publications (1)

Publication Number Publication Date
BR0213557A true BR0213557A (pt) 2004-10-26

Family

ID=26989581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213557-4A BR0213557A (pt) 2001-10-25 2002-10-24 Método para a sìntese de uma 2-aralquiloxiadenosina ou uma 2-alcoxiadenosina e processo para a preparação de um composto

Country Status (13)

Country Link
US (1) US6951932B2 (pt)
EP (1) EP1446413A4 (pt)
JP (1) JP2005511551A (pt)
KR (1) KR20040049001A (pt)
CN (1) CN1608076A (pt)
AU (1) AU2002336668B2 (pt)
BR (1) BR0213557A (pt)
CA (1) CA2465264C (pt)
IL (2) IL161608A0 (pt)
NO (2) NO326625B1 (pt)
NZ (1) NZ532541A (pt)
PL (1) PL369327A1 (pt)
WO (1) WO2003035662A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20070232561A1 (en) * 2006-03-31 2007-10-04 Edward Leung Pharmaceutical compositions for promoting wound healing
CA2700729A1 (en) 2007-10-19 2009-04-23 The University Of Tokyo Therapeutic agent for vitiligo and method of accelerating pigmentation
WO2009085909A1 (en) * 2007-12-20 2009-07-09 King Pharmaceuticals Research And Development, Inc. Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine
JP2020513192A (ja) 2017-03-29 2020-05-07 中国医学科学院基礎医学研究所 低分子ｒｎａ、並びに線維増殖性疾患及び／又は症候群の予防及び／又は治療におけるその応用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792155A (fr) * 1971-12-01 1973-05-30 Takeda Chemical Industries Ltd Nouveaux derives de l'adenosine et leur procede de production
JPS4911896A (pt) 1972-05-15 1974-02-01
JPS4920198A (pt) 1972-06-26 1974-02-22
JPS49124096A (pt) 1973-03-31 1974-11-27
JPS5053393A (pt) 1973-09-18 1975-05-12
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
AU6516494A (en) * 1993-04-15 1994-11-08 New York University Adenosine receptor agonists for the promotion of wound healing

Also Published As

Publication number Publication date
NO326625B1 (no) 2009-01-19
AU2002336668B2 (en) 2008-01-10
US6951932B2 (en) 2005-10-04
NO20083239L (no) 2004-06-23
IL161608A0 (en) 2004-09-27
WO2003035662A1 (en) 2003-05-01
AU2002336668B8 (en) 2003-05-06
PL369327A1 (en) 2005-04-18
US20030199686A1 (en) 2003-10-23
CA2465264C (en) 2010-09-07
EP1446413A1 (en) 2004-08-18
JP2005511551A (ja) 2005-04-28
EP1446413A4 (en) 2007-10-17
KR20040049001A (ko) 2004-06-10
CN1608076A (zh) 2005-04-20
IL161608A (en) 2010-05-31
NO20042126L (no) 2004-06-23
NZ532541A (en) 2005-09-30
CA2465264A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
PT100673A (pt) Processo para a preparacao de intermediarios de sertralina e compostos assim obtidos
CO5180579A1 (es) Composicion oral solida que comprende levidopa, carbidopa y entacapone
ITPD940042A0 (it) Processo per la preparazione di acido ialuronico mediante sintesi enzimatica e relative composizioni farmaceutiche
BR0309012A (pt) Uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para a preparação de um composto
BR0311242A (pt) Processo para preparar modafinil
BR0208992A (pt) Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR0317005A (pt) Processo para a preparação de compostos ativos opticamente puros
HUP9700886A2 (hu) Új tienil-etilamino-halogénfenil-acetonitril intermedierek és eljárás előállításukra
BR9905636A (pt) Processos para preparar um metaloaluminossilicato e para preparar uma composição de aluminossilicato, e, composição de metaloaluminossilicato
BR0215709A (pt) Processo para a preparação de cefdinir
BR0316702A (pt) xprocesso para preparação de (s)-pantoprazol
PT100672A (pt) Processo para a preparacao de intermediarios de sertralina e compostos assim obtidos
BR0316400A (pt) agentes branqueadores fluorescentes anfotéricos
BR0314128A (pt) Processo para o preparo de intermediários uteis para a sìntese de inibidores de tubulina
BR0212390A (pt) Processo para a preparação de cilastatina
DE60309251D1 (de) Verfahren zur Herstellung von Donepezil
BR9707931A (pt) Derivados sulfurados comportando um ligação amida seu processo de prepara sua aplicação a título de medicamentos e as composições farmacêuticas que os contêm
PT1102765E (pt) Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas
BR0211651A (pt) 3,5-dihidróxi-2,2-dimetil-valeronitrilas protegidas, para a sìntese de epotilonas e derivados e processos para produção e uso
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose
BR0116721A (pt) Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.